GB 18
Alternative Names: GB-18Latest Information Update: 25 Feb 2025
At a glance
- Originator Kexing Biopharm
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cachexia